Video
Michael Yeaman: Building Optimism in the Field of Neuromyelitis Optica
Author(s):
Unlike conditions like multiple sclerosis where there is a considerable amount of knowledge and several available approved treatment options that is not the case for neuromyelitis optica. As a result more work is needed to educate patients about what their treatment will be like.
Unlike conditions like multiple sclerosis where there is a considerable amount of knowledge and several available approved treatment options that is not the case for neuromyelitis optica. As a result more work is needed to educate patients about what their treatment will be like.
As a Medical Advisor to the Guthy Jackson Charitable Foundation, Michael R. Yeaman, PhD, has seen the work of the foundation make a big impact in moving the treatment of NMO forward in just a few short years. While it may be a few years before treatments are approved for the treatment of NMO, Yeaman said that is still a brighter picture than patients and their providers had just a few short years ago.
